HoJin Shin

Statistics

Publications

Citations

256

H-Index

Active since

2018

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

HoJin Shin is an author at Brigham and Women's Hospital specializing in type 2 diabetes pharmacotherapy, sodium-glucose cotransporter 2 inhibitors, and type 2 diabetes treatment.

ORCID

Publications per year

2018–2025

Publications

Relative Performance of Propensity Score Matching Strategies for Subgroup Analyses

Shirley Wang, Yinzhu Jin, Bruce Fireman et al. · American Journal of Epidemiology · 2018 · 124 citations

Public Health, Biostatistics, Causal Inference +16

Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA

HoJin Shin, Sebastian Schneeweiß, Robert J. Glynn et al. · Diabetes Care · 2021 · 73 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium–Glucose Cotransporter-2 Inhibitors Versus Metformin

HoJin Shin, Sebastian Schneeweiß, Robert J. Glynn et al. · Annals of Internal Medicine · 2022 · 41 citations

Pharmacy, Pharmacotherapy, Cardiovascular Pharmacotherapy +16

Comparative Effectiveness of Individual Sodium-Glucose Cotransporter 2 Inhibitors

HoJin Shin, Julie M. Paik, Brendan M. Everett et al. · JAMA Internal Medicine · 2025 · 18 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–4 of 4